Glenamrk’s anti-myelona drug receives clinical trial approval from USFDA
Glenmark Pharma has got the US health regulator’s approval for its investigational new drug application to initiate phase one study of GBR 1342, a humanised...
Download Unicorn Signals App
Powered By EquityPandit
